GPX4 and nonpapillary renal cell carcinoma: Zou et al. found that GPX4 inhibitors effectively destroyed renal clear carcinoma cells, and their further investigation demonstrated that overexpression of hypoxia-inducible factor 2α (HIF-2α) could significantly enhance the ferroptosis sensitivity of ccRCC by enriching PUFAs 77.